Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Synthesis and in-vivo hypolipidemic activity of some novel substituted phenyl isoxazol phenoxy acetic acid derivatives.

Mokale SN, Nevase MC, Sakle NS, Dube PN, Shelke VR, Bhavale SA, Begum A.

Bioorg Med Chem Lett. 2014 May 1;24(9):2155-8. doi: 10.1016/j.bmcl.2014.03.030. Epub 2014 Mar 21.

PMID:
24703232
2.

Synthesis and hypolipidemic activity of novel 2-(4-(2-amino-6-(4-substituted phenyl) pyrimidin-4-yl)-2-substituted phenoxy) acetic acid derivatives.

Mokale SN, Shete MT, Shaikh SI, Shinde DB.

Chem Biol Drug Des. 2012 Apr;79(4):548-52. doi: 10.1111/j.1747-0285.2012.01319.x. Epub 2012 Jan 30.

PMID:
22226122
3.

Microwave-assisted synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-Amino-6-(4-substituted phenyl)-pyrimidin-4-yl)-phenoxy)-2-methyl propanoic acid derivatives.

Mokale SN, Elgire RD, Sakle NS, Shinde DB.

Arch Pharm (Weinheim). 2012 Jan;345(1):22-7. doi: 10.1002/ardp.201000229. Epub 2011 Nov 11.

PMID:
22076967
4.

2,5,6-trisubstituted imidazo[2,1-b][1,3,4]thiadiazoles: search for antihyperlipidemic agents.

Patel HM, Noolvi MN, Goyal A, Thippeswamy BS.

Eur J Med Chem. 2013 Jul;65:119-33. doi: 10.1016/j.ejmech.2013.04.020. Epub 2013 Apr 18.

PMID:
23707917
5.

Antihyperlipidemic properties of novel N-(benzoylphenyl)-5-substituted-1H-indole-2-carboxamides in Triton WR-1339-induced hyperlipidemic rats.

Al-Hiari Y, Shattat G, Al-Qirim T, El-Huneidi W, Sheikha GA, Hikmat S.

Molecules. 2011 Sep 29;16(10):8292-304. doi: 10.3390/molecules16108292.

6.

Synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-substituted aminothiazole-4-yl) phenoxy)-2-methyl propanoic acid derivatives.

Mokale SN, Elgire RD, Sakle N, Shinde DB.

Bioorg Med Chem Lett. 2011 Jan 15;21(2):682-5. doi: 10.1016/j.bmcl.2010.12.011. Epub 2010 Dec 8.

PMID:
21193309
7.

Synthesis of novel N-(4-benzoylphenyl)-2-furamide derivatives and their pharmacological evaluation as potent antihyperlipidemic agents in rats.

Al-Qirim T, Shattat G, Sheikha GA, Sweidan K, Al-Hiari Y, Jarab A.

Drug Res (Stuttg). 2015 Mar;65(3):158-63. doi: 10.1055/s-0034-1375646. Epub 2014 May 21.

PMID:
24848001
8.

Synthesis and antihyperlipidemic activity of some novel 4-(substitutedamino)-5-substituted-3-mercapto- (4H)-1,2,4-triazoles.

Chhabria MT, Suhagia BN, Brahmkshatriya PS, Raval PM.

Arzneimittelforschung. 2011;61(8):452-7.

PMID:
21950149
9.

Hypolipidemic activity of Phellinus rimosus against triton WR-1339 and high cholesterol diet induced hyperlipidemic rats.

Rony KA, Ajith TA, Nima N, Janardhanan KK.

Environ Toxicol Pharmacol. 2014 Mar;37(2):482-92. doi: 10.1016/j.etap.2014.01.004. Epub 2014 Jan 26.

PMID:
24561532
10.

The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate.

Shattat G, Al-Qirim T, Sweidan K, Shahwan M, El-Huneidi W, Al-Hiari Y.

J Enzyme Inhib Med Chem. 2010 Dec;25(6):751-5. doi: 10.3109/14756360903389880. Epub 2010 Jun 30.

PMID:
20590406
11.

The pharmacological effects of novel 5-fluoro-N-(9,10-dihydro-9,10-dioxoanthracen-8-yl)-1H-indole-2-carboxamide derivatives on plasma lipid profile of Triton-WR-1339-induced Wistar rats.

Shattat G, Al-Qirim T, Sheikha GA, Al-Hiari Y, Sweidan K, Al-Qirim R, Hikmat S, Hamadneh L, Al-Kouz S.

J Enzyme Inhib Med Chem. 2013 Aug;28(4):863-9. doi: 10.3109/14756366.2012.692085. Epub 2012 May 31.

PMID:
22651797
13.

Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.

Sashidhara KV, Dodda RP, Sonkar R, Palnati GR, Bhatia G.

Eur J Med Chem. 2014 Jun 23;81:499-509. doi: 10.1016/j.ejmech.2014.04.085. Epub 2014 May 14.

PMID:
24871900
14.

Synthesis and anti-hyperlipidemic evaluation of N‑(benzoylphenyl)-5-fluoro-1H-indole-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats.

Shattat G, Al-Qirim R, Al-Hiari Y, Sheikha GA, Al-Qirim T, El-Huneidi W, Shahwan M.

Molecules. 2010 Aug 26;15(9):5840-9. doi: 10.3390/molecules15095840.

15.

Hypolipidaemic and antiplatelet activity of phenoxyacetic acid derivatives related to alpha-asarone.

Pérez-Pastén R, García RV, Garduño L, Reyes E, Labarrios F, Tamariz J, Chamorro G.

J Pharm Pharmacol. 2006 Oct;58(10):1343-9.

PMID:
17034657
16.

[The action of a fibric acid derivative on lipid metabolism].

Filip M, Păduraru I, Nechifor M, Dănilă GH, Popovici I, Filip FM, Poşircă F.

Rev Med Chir Soc Med Nat Iasi. 1989 Jul-Sep;93(3):573-6. Romanian.

PMID:
2636755
17.

Design, synthesis and biological evaluation of some 2-azetidinone derivatives as potential antihyperlipidemic agents.

Arya N, Dwivedi J, Khedkar VM, Coutinho EC, Jain KS.

Arch Pharm (Weinheim). 2013 Dec;346(12):872-81. doi: 10.1002/ardp.201300262. Epub 2013 Oct 20.

PMID:
24142910
18.

Indole-based fibrates as potential hypolipidemic and antiobesity agents.

Sashidhara KV, Kumar M, Sonkar R, Singh BS, Khanna AK, Bhatia G.

J Med Chem. 2012 Mar 22;55(6):2769-79. doi: 10.1021/jm201697v. Epub 2012 Mar 2.

PMID:
22339404
19.

Synthesis and antihyperlipidemic activity of some novel condensed 2-chloroalkyl-4-chloro/hydroxy-5,6-disubstituted pyrimidines.

Kathiravan MK, Shishoo CJ, Kumar KG, Roy SK, Mahadik KR, Kadam SS, Jain KS.

Arzneimittelforschung. 2007;57(9):599-606.

PMID:
17966759
20.

In vitro antioxidant and antihyperlipidemic activities of Toddalia asiatica (L) Lam. leaves in Triton WR-1339 and high fat diet induced hyperlipidemic rats.

Irudayaraj SS, Sunil C, Duraipandiyan V, Ignacimuthu S.

Food Chem Toxicol. 2013 Oct;60:135-40. doi: 10.1016/j.fct.2013.07.035. Epub 2013 Jul 25.

PMID:
23891761

Supplemental Content

Support Center